Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€75.17

€75.17

-0.410%
-0.31
-0.410%
-

-

 
12:04 / Tradegate WKN: A3D3G6 / Name: Ge Healthcare Technologies Inc / Stock / ? /

Ge Healthcare Technologies Inc Stock

Ge Healthcare Technologies Inc shows a slight decrease today, losing -€0.310 (-0.410%) compared to yesterday.

Pros and Cons of Ge Healthcare Technologies Inc in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease: https://mms.businesswire.com/media/20230105005172/en/1673594/5/GE_HealthCare_Logo_%28Jan_2023%29.jpg
GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease


Today, GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software

GE HealthCare to Hold an Investor Day in New York City on November 21, 2024: https://mms.businesswire.com/media/20230105005172/en/1673594/5/GE_HealthCare_Logo_%28Jan_2023%29.jpg
GE HealthCare to Hold an Investor Day in New York City on November 21, 2024


GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will host an investor day on Thursday, November 21, 2024, in New York, NY. GE HealthCare’s management team will present its

Pushing the Boundaries of Neuroscience with GE HealthCare’s SIGNA MAGNUS: https://mms.businesswire.com/media/20230105005172/en/1673594/5/GE_HealthCare_Logo_%28Jan_2023%29.jpg
Pushing the Boundaries of Neuroscience with GE HealthCare’s SIGNA MAGNUS


GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been